Skip to content
MEDIBIOFARMA SL logo — To make disease-modifying treatments available to patients w...

MEDIBIOFARMA SL

To make disease-modifying treatments available to patients with serious or life-threatening conditions

Founded 2016 Spain Spain 8 employees Venture round Total: $2.42M Biotechnology, Health Care

General Information

Company Name MEDIBIOFARMA SL
Founded Year 2016
Location Spain Spain
Employees 8
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with MEDIBIOFARMA SL. To contact MEDIBIOFARMA SL, visit medibiofarma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MEDIBIOFARMA SL compare?

A PDF of MEDIBIOFARMA SL and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MEDIBIOFARMA SL soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MEDIBIOFARMA SL

MEDIBIOFARMA SL is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. The company's slogan "To make disease-modifying treatments available to patients with serious or life-threatening conditions" encapsulates its vision. Medibiofarma aims to generate innovative and high-quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases. Specializing in Biotechnology and Health Care, the company is headquartered in Spain. The latest investment, a grant investment at 20 March 2023, came from the Crohn's & Colitis Foundation. This shows the confidence that notable organizations have in MEDIBIOFARMA SL's potential to develop disease-modifying treatments.

Business keywords: clinical-stage, research programs, drug discovery, therapeutic targets, cancer treatment, non-cancer diseases, disease-modifying treatments, pharmaceutical industry, innovation, lifethreatening conditions, Medibiofarma S.L, biopharmaceutical, medical research

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €1.00M 2
Inveready, SODENA
03 Apr 2024
Grant Undisclosed 1
Crohn's & Colitis Foundation
20 Mar 2023
Venture Round €300.00K 1
SODENA
15 Mar 2022
Funding Round €115.00K 1
SODENA
01 Jan 2020
Funding Round $1.00M 1
SODENA
01 Jan 2019

MEDIBIOFARMA SL Alternatives & Competitors

View All Alternatives
MEDIBIOFARMA SL vs
Nimbus Therapeutics
Nimbus Therapeutics United States

We develop breakthrough medicines for patients through precision small molecule design.

103 employees
Biotechnology, Health Care
MEDIBIOFARMA SL vs
Redx Pharma
Redx Pharma United Kingdom

Biotech company focusing on the discovery and development of novel targeted medicines to treat cance...

Post-IPO Equity
39 employees
Biotechnology, Health Care
MEDIBIOFARMA SL vs

Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse disease states.

Venture round
Biotechnology, Health Care

FAQ About MEDIBIOFARMA SL

To make disease-modifying treatments available to patients with serious or life-threatening conditions
MEDIBIOFARMA SL was founded in 2016.
MEDIBIOFARMA SL is headquartered in Spain.
MEDIBIOFARMA SL operates in Biotechnology and Health Care. Its work centres on clinical-stage, research programs, drug discovery and therapeutic targets.
MEDIBIOFARMA SL has approximately 8 employees.
MEDIBIOFARMA SL has completed 5 funding rounds, raising a total of $2.42M. The latest funding stage is Venture round.
Top alternatives and competitors to MEDIBIOFARMA SL include Nimbus Therapeutics, Redx Pharma, Santaris Pharma, Apitope, Tango Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MEDIBIOFARMA SL and Nimbus Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MEDIBIOFARMA SL, https://bouncewatch.com/company/medibiofarma-sl, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout